Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

81.86 +1.02 (+1.27%)

Streaming Delayed Price Updated: 3:49 PM EDT, Jul 24, 2026 Add to My Watchlist

Price and Volume

Volume	1,194,423
Open	81.35
Bid (Size)	81.83 (100)
Ask (Size)	81.90 (200)
Prev. Close	80.84
Today's Range	80.93 - 82.99
52wk Range	57.33 - 82.26
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

Today 0:41 EDT

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

1 Value Stock Worth Investigating and 2 Facing Headwinds

July 15, 2026

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...

Via StockStory

Performance

YTD	+16.4%	+16.4%
1 Month	+17.6%	+17.6%
3 Month	+22.9%	+22.9%
6 Month	+14.8%	+14.8%
1 Year	+39.8%	+39.8%

More News

2 Reasons to Like HALO and 1 to Stay Skeptical

July 10, 2026

Via StockStory

1 Surging Stock for Long-Term Investors and 2 We Brush Off

July 01, 2026

Via StockStory

Halozyme Therapeutics (NASDAQ:HALO): A Value Stock Profile Offering Strong Profitability and a Low Forward P/E ↗

June 25, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO): A Deep Value Play Combining Strong Profitability with an Attractive 14.35 P/E ↗

June 03, 2026

Via Chartmill

Halozyme Therapeutics (NASDAQ:HALO) Surges After Q1 Beat, Launches $1 Billion Buyback ↗

May 11, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗

March 06, 2026

Via Chartmill

2 Profitable Stocks Worth Your Attention and 1 We Question

June 18, 2026

Via StockStory

Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today

June 03, 2026

Via StockStory

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 18, 2026

Via StockStory

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

May 13, 2026

Via StockStory

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

May 12, 2026

Via StockStory

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

May 12, 2026

Via StockStory

Halozyme (HALO) Q1 2026 Earnings Transcript ↗

May 11, 2026

Via The Motley Fool

Halozyme Therapeutics Q1 Earnings Call Highlights ↗

May 11, 2026

Via MarketBeat

Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates

May 11, 2026

Via StockStory

Halozyme Therapeutics Earnings: What To Look For From HALO

May 09, 2026

Via StockStory

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 That Underwhelm

April 21, 2026

Via StockStory

3 Cash-Producing Stocks with Exciting Potential

April 10, 2026

Via StockStory

2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore

April 09, 2026

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

April 08, 2026

Via StockStory

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

March 24, 2026

Via StockStory

2 Reasons to Like HALO (and 1 Not So Much)

February 24, 2026

Via StockStory

Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Via The Motley Fool

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 81.86

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 07/24/26 03:49 PM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 11.65B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 12B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.